Get started
China Medical System Holdings Ltd.China Medical System Holdings Ltd.China Medical System Holdings Ltd.

China Medical System Holdings Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

2M7C chart


Full chart

2M7C upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.67 B‬ EUR
Dividend yield (indicated)
2.17%
Price to earnings Ratio (TTM)
18.3042
Basic EPS (TTM)
0.0792 EUR
Net income (FY)
‪218.30 M‬ EUR
Revenue (FY)
‪1.01 B‬ EUR
Shares float
‪1.19 B‬
Beta (1Y)
0.92

Employees


Employees (FY)
‪6.14 K‬
Change (1Y)
+440 +7.72%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About China Medical System Holdings Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Kong Lam
Website
cms.net.cn
Headquarters
Shenzhen
Founded
1995
ISIN
KYG211081248
FIGI
BBG00162N947
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. Its products include Plendil, Ursofalk, Deanxit, Xinhuosu, Salofalk, BIOFLOR, Augentropfen Stulln Mono, Hirudoid, Combizym, Tanshinone Capsules, Yinuoshu, Nuodikang Capsules, Xidakang, Ganfule Capsules, Imdur, Parlodel, Elcitonin, Lamisil, Yinlian Qinggan Granules, MOVICOL. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.

Check out other big names from the same industry as 2M7C.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

2M7C news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange China Medical System Holdings Ltd. stocks are traded under the ticker 2M7C.
We've gathered analysts' opinions on China Medical System Holdings Ltd. future price: according to them, 2M7C price has a max estimate of 1.99 EUR and a min estimate of 1.66 EUR. Watch 2M7C chart and read a more detailed China Medical System Holdings Ltd. stock forecast: see what analysts think of China Medical System Holdings Ltd. and suggest that you do with its stocks.
2M7C reached its all-time high on Apr 20, 2009 with the price of 62.9900 EUR, and its all-time low was 0.6838 EUR and was reached on Jun 17, 2019. View more price dynamics on 2M7C chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track China Medical System Holdings Ltd. financials in yearly and quarterly reports right on TradingView.
China Medical System Holdings Ltd. is going to release the next earnings report on Mar 17, 2026. Keep track of upcoming events with our Earnings Calendar.
2M7C earnings for the last half-year are 0.05 EUR per share, whereas the estimation was 0.04 EUR, resulting in a 5.19% surprise. The estimated earnings for the next half-year are 0.04 EUR per share. See more details about China Medical System Holdings Ltd. earnings.
China Medical System Holdings Ltd. revenue for the last half-year amounts to ‪474.09 M‬ EUR, despite the estimated figure of ‪474.01 M‬ EUR. In the next half-year revenue is expected to reach ‪519.14 M‬ EUR.
2M7C net income for the last half-year is ‪109.29 M‬ EUR, while the previous report showed ‪95.65 M‬ EUR of net income which accounts for 14.26% change. Track more China Medical System Holdings Ltd. financial stats to get the full picture.
China Medical System Holdings Ltd. dividend yield was 3.85% in 2024, and payout ratio reached 40.22%. The year before the numbers were 3.09% and 39.56% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 3, 2025, the company has ‪6.14 K‬ employees. See our rating of the largest employees — is China Medical System Holdings Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. China Medical System Holdings Ltd. EBITDA is ‪224.34 M‬ EUR, and current EBITDA margin is 25.58%. See more stats in China Medical System Holdings Ltd. financial statements.
Like other stocks, 2M7C shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade China Medical System Holdings Ltd. stock right from TradingView charts — choose your broker and connect to your account.